Cargando…

Mitigating ipatasertib‐induced glucose increase through dose and meal timing modifications

Ipatasertib, an AKT inhibitor, in combination with prednisone and abiraterone, is under evaluation for the treatment of metastatic castration‐resistant prostate cancer (mCRPC). Hyperglycemia is an on‐target effect of ipatasertib. An open‐label, single‐arm, single‐sequence, signal‐seeking study (n = ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutaria, Dhruvitkumar S., Agarwal, Priya, Huang, Kuan‐Chieh, Miles, Dale R., Rotmensch, Jacob, Hinton, Heather, Gallo, Jorge Daniel, Rasuo, Grozdana, Sane, Rucha S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747122/ https://www.ncbi.nlm.nih.gov/pubmed/36197694 http://dx.doi.org/10.1111/cts.13420

Ejemplares similares

Drug–Drug Interaction Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ipatasertib in Combination with Darolutamide in Patients with Advanced Prostate Cancer
por: Sutaria, Dhruvitkumar S., et al.
Publicado: (2022)

Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using 2 Methods of Classification of Hepatic Function
por: Sane, Rucha, et al.
Publicado: (2021)

Characterization of exposure–response relationships of ipatasertib in patients with metastatic castration-resistant prostate cancer in the IPATential150 study
por: Kotani, Naoki, et al.
Publicado: (2022)

Assessment of cytochrome P450 3A4-mediated drug–drug interactions for ipatasertib using a fit-for-purpose physiologically based pharmacokinetic model
por: Jing, Jing, et al.
Publicado: (2022)

Ipatasertib exhibits anti-tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo
por: O'donnell, Jillian, et al.
Publicado: (2023)

Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer Cells
por: Laterza, Maria Maddalena, et al.
Publicado: (2021)

Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma
por: Burkett, Wesley C., et al.
Publicado: (2023)

Exposure–Response‐Based Product Profile–Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer
por: Zhu, Rui, et al.
Publicado: (2019)

The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer
por: THAKKAR, ARVIND, et al.
Publicado: (2013)

Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen
por: SUTARIA, DHRUVITKUMAR, et al.
Publicado: (2012)

Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer
por: Yuan, Yuan, et al.
Publicado: (2023)

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors
por: Doi, Toshihiko, et al.
Publicado: (2019)

Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer
por: Shi, Zhen, et al.
Publicado: (2022)

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
por: Turner, Nicholas, et al.
Publicado: (2021)

Una excursión por el cielo
por: Olujic, Grozdana
Publicado: (1964)

Quantitative Prediction of OATP‐Mediated Drug‐Drug Interactions With Model‐Based Analysis of Endogenous Biomarker Kinetics
por: Yoshida, Kenta, et al.
Publicado: (2018)

Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis
por: Sun, Li, et al.
Publicado: (2018)

Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells
por: Morgillo, Floriana, et al.
Publicado: (2017)

Modification of the equine gastrointestinal microbiota by Jerusalem artichoke meal supplementation
por: Glatter, M., et al.
Publicado: (2019)

Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics
por: Bulitta, Jürgen B., et al.
Publicado: (2019)

Recent modifications of free gingival graft: A case series
por: Shah, Rucha, et al.
Publicado: (2015)

Cricket Meal (Gryllus bimaculatus) as a Protein Supplement on In Vitro Fermentation Characteristics and Methane Mitigation
por: Phesatcha, Burarat, et al.
Publicado: (2022)

Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma
por: Sutaria, Dhruvitkumar S., et al.
Publicado: (2017)

Exploiting the dynamic properties of covalent modification cycle for the design of synthetic analog biomolecular circuitry
por: Foo, Mathias, et al.
Publicado: (2016)

Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding
por: Shah, Nirav R., et al.
Publicado: (2019)

Requested meals versus scheduled meals
por: Ciampolini, Mario
Publicado: (2012)

CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128
por: Badawi, Mohamed, et al.
Publicado: (2018)

Loss of RE-1 silencing transcription factor accelerates exocrine damage from pancreatic injury
por: Bray, Julie K., et al.
Publicado: (2020)

Egg-Albumin and Glucose Test Meal
Publicado: (1911)

Learning a Health Knowledge Graph from Electronic Medical Records
por: Rotmensch, Maya, et al.
Publicado: (2017)

Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
por: Zhu, Xiaohua, et al.
Publicado: (2017)

Origin and Mitigation of the Beam-Induced Surface Modifications of the LHC Beam Screens
por: Petit, Valentine, et al.
Publicado: (2022)

Behavioral modifications by a large-northern herbivore to mitigate warming conditions
por: Jennewein, Jyoti S., et al.
Publicado: (2020)

Meal Timing, Meal Frequency and Metabolic Syndrome
por: Alkhulaifi, Fatema, et al.
Publicado: (2022)

Bacillus amyloliquefaciens CU33 fermented feather meal-soybean meal product improves the intestinal morphology to promote the growth performance of broilers
por: Lee, Tsung-Yu, et al.
Publicado: (2022)

Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer
por: Sutaria, Dhruvitkumar S., et al.
Publicado: (2019)

Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery
por: Sutaria, Dhruvitkumar S., et al.
Publicado: (2017)

Modification of Gut Microbiota and Immune Responses via Dietary Protease in Soybean Meal-Based Protein Diets
por: Song, Minho, et al.
Publicado: (2022)

Effect of Pseudocereal-Based Breakfast Meals on the First and Second Meal Glucose Tolerance in Healthy and Diabetic Subjects
por: Gabrial, Shreef G. N., et al.
Publicado: (2016)

Energy concentration and phosphorus digestibility in meat meal, fish meal, and soybean meal fed to pigs
por: Kong, Changsu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cmppekjr4fbndrh388q1gfjus7